Sanjay Subramanian

Insider Reports History

Location
Malvern, PA
Signature
/s/ Sanjay Subramanian
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sanjay Subramanian:

Form 4 holding SVP, CFO & Head of BD

Inozyme Pharma, Inc.

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$171,325
Report date
01 Jul 2025
Price
$4.45
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Ocugen, Inc.

Security class
Common Stock
Shares / value
161,125
Estimated value
$105,215
Report date
03 Jan 2022
Price
$0.6530
Ownership
Direct
Form 4 holding Chief Financial Officer

Ocugen, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
454,007
Estimated value
Report date
03 Jan 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Ocugen, Inc.

Security class
Option(Right toBuy)
Shares / value
71,120
Estimated value
Report date
16 Dec 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP, CFO & Head of BD

Inozyme Pharma, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
01 Jul 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Sanjay Subramanian

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .